Encephalitis: all 284 studies
Page 1 of 3. Open to participants first (56), then studies with results posted, then the rest; newest registration first within each.
- [11C]PS13 PET Imaging of Neuroinflammation in Heart Failure With Reduced Ejection FractionNot yet recruitingNCT07856043Phase 1
- Group-based Emotional Awareness and Expression Therapy to Support Recovery After Acquired Brain Injury: A Clinical Development and Evaluation StudyRecruitingNCT07852936Not applicable
- Early Neurological Outcome in Pediatric EncephalitisNot yet recruitingNCT07830927
- Recovery Trajectory for Coma and Disorders of ConsciousnessRecruitingNCT07614074
- KD Treatment for Super-refractory Status EpilepticusRecruitingNCT07496749Not applicable
- Prediction of Infectious Agents in the Biofire® FilmArray bioMérieux Meningitis/Encephalitis Panel Based on Clinical Syndrome and Cerebrospinal Fluid Parameters: a Diagnostic Stewardship Proposal.RecruitingNCT07432113Not applicable
- Optic Nerve Ultrasound for Assessing Cerebral Inflammation and Intracranial Hypertension in Cerebral PathologiesRecruitingNCT07332234
- Burden of Tick-borne Encephalitis and Cost-effectiveness of Vaccination in the Czech RepublicRecruitingNCT07274046
- Clinicolaboratory Predictors of Outcome in Children With EncephalitisNot yet recruitingNCT07241858
- Evolving Diagnostic Approaches to Undocumented Lymphocytic Meningitis and MeningoencephalitisEnrolling by invitationNCT07186881
- A Study in Participants With Anti-NMDAR Encephalitis and Anti-NMDAR Autoantibody-Associated Psychiatric DiseaseRecruitingNCT07093333Phase 2
- Causes of Secondary and Prolonged Fever During Treatment of Bacterial Meningitis and Viral EncephalitisNot yet recruitingNCT06971133
- Serological Measurement of Montpellier Professionals' Contacts with Infectious Agents Responsible for Animal-borne DiseasesNot yet recruitingNCT06859619Not applicable
- Predictive BioMArkers of AlTERed NeurologicAL Trajectories Consequent to PrenataL InflammatorY InsultsRecruitingNCT06852703
- Inflammatory and Metabolic Prognostic Assessment in Critically Ill Neurological PatientsNot yet recruitingNCT06849011
- A Multicentric Cohort of Autoimmune EncephalitisNot yet recruitingNCT06760091
- Risk Prediction Model for Severe Autoimmune EncephalitisNot yet recruitingNCT06697678
- Herpes Simplex Meningo Encephalitis RecurrenceRecruitingNCT06627010
- Efficacy and Safety of Calculus Bovis Sativus (CBS) for Adult Encephalitis (CBSinEncephalitis)RecruitingNCT06584045Not applicable
- Antibody-mediated LGI1 Encephalitis: Symptoms, Biomarkers, and Mechanisms of the Chronic Phase of the DiseaseRecruitingNCT06515106Not applicable
- Early Interferon-beta Treatment for West-Nile Virus InfectionRecruitingNCT06510426Phase 2
- Efficacy and Safety of Taitacept in Treatment of Refractory or Recurrent Anti-NMDAR/anti-LGI1 EncephalitisRecruitingNCT06510283Phase 2
- Clinical Features and Prognostic Markers in Adult Patients With AE Requiring ICU TreatmentNot yet recruitingNCT06456736
- National, Multicentric Registry Study on Neuroimmunological Diseases in ChinaRecruitingNCT06443333
- CoMind Early Feasibility StudyRecruitingNCT06368648
- Retrospective Analysis of the French National Cohort of Patients With GAD Antibodies and Cerebellar AtaxiaRecruitingNCT06334900
- Improving Diagnosis and Prediction of Outcome in Patients With Severe Disorders of ConsciousnessRecruitingNCT06283901
- Brain MRI Longitudinal Volumetric Characteristics Associated With Outcomes of CASPR2-Limbic EncephalitisRecruitingNCT06245447
- Antibody-mediated NMDA Receptor Encephalitis: Symptoms, Biomarkers, and Mechanisms of the Prolonged Recovery StageRecruitingNCT06183788Not applicable
- MCLENA-2: A Phase II Clinical Trial for the Assessment of Lenalidomide in Patients With Mild Cognitive ImpairmentNot yet recruitingNCT06177028Phase 2
- Iron Fortified Food to Improve Japanese Encephalitis and Typhoid Fever Vaccine ImmunogenicityRecruitingNCT06027801Not applicable
- Plaque and Brain Inflammation in Symptomatic Carotid Stenosis: Role of the Ficolin-2RecruitingNCT05850247Phase 2
- Characterization of Immune-response in Autoimmune Encephalitis and Paraneoplastic Neurological SyndromesRecruitingNCT05772611
- Predicting and Monitoring Outcomes in Autoimmune EncephalitisNot yet recruitingNCT05711563
- Investigation of Prognostic Biomarkers, Host Factors and Viral Factors for COVID-19 in ChildrenRecruitingNCT05576714
- An Experimental Medicine Decipher of a Minimum Correlate of Cellular ImmunityRecruitingNCT05568953Phase 2
- Longterm Influence of Pediatric Long COVID SyndromeRecruitingNCT05566392
- Acute Sympotomatic Seizure Secondary to Autoimmune Encephalitis and Autoimmune-associated EpilepsyEnrolling by invitationNCT05422664
- Regulating Emotions and Behaviors After Brain InjuryRecruitingNCT05393492Not applicable
- Developing Advanced Neuroimaging for Clinical Evaluation of Autoimmune EncephalitisRecruitingNCT05280600
- GWAS in NMDAR EncephalitisRecruitingNCT05225883
- Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis CollectionRecruitingNCT05198661Not applicable
- Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)RecruitingNCT05017142
- HLA Analysis in Autoimmune Encephalitis and Related Disorders: Part IIRecruitingNCT04823728
- Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation ResearchRecruitingNCT04806620
- Establishment of Prevention and Control System of Central Nervous System InfectionNot yet recruitingNCT04722328
- Primary TBE Vaccination for the ElderlyNot yet recruitingNCT04573205Phase 4
- Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous SystemRecruitingNCT04561557Early Phase 1
- The ExTINGUISH Trial of Inebilizumab in NMDAR EncephalitisRecruitingNCT04372615Phase 2
- Study on Patients With Rasmussen Encephalitis Treated With Adalimumab: Efficacy and Tolerance in the Short and Long TermRecruitingNCT04003922
- Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune EncephalitisRecruitingNCT03993262Phase 2
- Tick-borne Encephalitis and Borrelial Antibodies in SerumRecruitingNCT03956446Not applicable
- Central Nervous System Infections in DenmarkRecruitingNCT03418441
- Fosfomycin I.v. for Treatment of Severely Infected PatientsRecruitingNCT02979951
- Genetic and Electrophysiologic Study in Focal Drug-resistant EpilepsiesRecruitingNCT02890641
- Natural History Study of Progressive Multifocal Leukoencephalopathy (PML)RecruitingNCT01730131
- Study to Evaluate the Immunogenicity, Safety, and Tolerability of a Tick-Borne Encephalitis (TBE) Vaccine in Healthy Japanese Participants 1 Year of Age and OlderCompletedNCT04648241Phase 3Results posted
- Flavivirus Cross-priming Potential of IMOJEVCompletedNCT03920111Not applicableResults posted
- VRC 313: A Trivalent Virus-like Particle (VLP) Encephalitis Vaccine (WEVEE) in Healthy AdultsCompletedNCT03879603Phase 1Results posted
- Efficacy of Ocrelizumab in Autoimmune EncephalitisTerminatedNCT03835728Phase 2Results posted
- Modulating ApoE Signalling to Reduce Brain Inflammation, deLirium and postopErative Cognitive DysfunctionCompletedNCT03802396Phase 2Results posted
- TSPO PET as a Measure of Post-stroke Brain Inflammation: a Natural History CohortCompletedNCT03662750Not applicableResults posted
- Precision Diagnosis of Acute Infectious Diseases; Neuroinflammatory CohortCompletedNCT02910037Not applicableResults posted
- Immunogenicity and Safety of Japanese Encephalitis Vaccine When Given With Measles-Mumps-Rubella (MMR) VaccineCompletedNCT02880865Phase 4Results posted
- tDCS and Cognition in Adults With Multiple Sclerosis or EncephalitisCompletedNCT02538094Not applicableResults posted
- Immunogenicity of a Live Attenuated Chimeric JE Vaccine (IMOJEV) as a Booster Dose in Thai Children Primed With CD.JEVAXCompletedNCT02526550Phase 4Results posted
- Long-term Immunogenicity After Receipt of JE Vaccine and Antibody Response and Safety to a Booster DoseCompletedNCT02514746Phase 4Results posted
- TBE (Tick-borne Encephalitis) Vaccination in Allergic PatientsCompletedNCT02511535Phase 4Results posted
- Study of a Single Primary Dose Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV®) in Healthy SubjectsCompletedNCT02492165Phase 3Results posted
- Humoral and Cellular Immunity for TBE Vaccination in Allogeneic HSCT RecipientsCompletedNCT01991067Phase 2Results posted
- Post-licensure Safety Study of IMOJEV® in ThailandCompletedNCT01981967Phase 4Results posted
- Study of a Booster Dose of IMOJEV® One Year After Primary Immunization in Healthy Children in South KoreaCompletedNCT01900444Phase 3Results posted
- Safety and Immunogenicity of 2 Different Vaccination Schedules of Rabies and Japanese Encephalitis Vaccines in Healthy Adult SubjectsCompletedNCT01662440Phase 3Results posted
- A Prospective, Open Label Study of Human T Cell Responses to Live Attenuated Japanese Encephalitis Vaccine SA14-14-2CompletedNCT01656200Phase 4Results posted
- Lot-to-lot Consistency Trial of Japanese Encephalitis Live Attenuated SA 14-14-2 VaccineCompletedNCT01567865Phase 4Results posted
- Study to Evaluate Long Term Immunogenicity up to 10 Years After the First Booster Immunization With Tick Borne Encephalitis Vaccine in Adults Who Received 1 of 3 Different Primary Vaccination SchedulesCompletedNCT01562444Phase 4Results posted
- IVIG Treatment for Refractory Immune-Related Adult EpilepsyTerminatedNCT01545518Phase 2Results posted
- A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in AdultsCompletedNCT01466387Phase 3Results posted
- Immunogenicity and Safety of Inactivated Vero Cell Derived Japanese Encephalitis Vaccine in Thai ChildrenCompletedNCT01408537Phase 3Results posted
- Study of a Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV™) Compared to CD.JEVAX™ in ToddlersCompletedNCT01396512Phase 3Results posted
- Open-label, Randomized Study in a Pediatric Population in a JEV (Japanese Encephalitis Virus)-Endemic CountryCompletedNCT01296360Phase 3Results posted
- Long Term Immunity and Safety Following Vaccination With the JEV IC51 (IXIARO®, JESPECT®) in Pediatric Population In Non Endemic Countries. Uncontrolled, Ph3 FU-StudyCompletedNCT01246479Phase 3Results posted
- Study of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children Previously Immunized With JE-CVCompletedNCT01190228Phase 3Results posted
- Study of Japanese Encephalitis Chimeric Virus Vaccine Given With Measles-Mumps-Rubella Vaccine in Taiwanese ToddlersCompletedNCT01188343Phase 3Results posted
- A Study of Japanese Encephalitis Chimeric Virus Vaccine Compared With SA14-14-2 Vaccine in Infants and ToddlersCompletedNCT01092507Phase 3Results posted
- Immunogenicity and Safety of the Japanese Encephalitis Vaccine IC51 (IXIARO®, JESPECT®) in a Pediatric Population in Non-endemic CountriesCompletedNCT01047839Phase 3Results posted
- Safety and Immunogenicity of the Japanese Encephalitis Vaccine IC51 (IXIARO®) in a Pediatric PopulationCompletedNCT01041573Phase 3Results posted
- Vaccine Study for Tick-Borne Encephalitis Virus (TBEV)TerminatedNCT01031537Phase 2Results posted
- Long-term Follow-up of Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in ToddlersCompletedNCT01001988Phase 3Results posted
- Study of Live Attenuated Japanese Encephalitis Vaccine (ChimeriVax™-JE) and Yellow Fever Vaccine (STAMARIL®)CompletedNCT00982137Phase 2Results posted
- Study of Live Attenuated ChimeriVax™-Japanese Encephalitis VaccineCompletedNCT00981630Phase 2Results posted
- A Study of ChimeriVax™-JE Live Attenuated Vaccine in Healthy AdultsCompletedNCT00981175Phase 2Results posted
- Treatment of West Nile Virus With MGAWN1TerminatedNCT00927953Phase 2Results posted
- Tick-Borne Encephalitis (TBE) Seropersistence After First Booster and Response to a Second Booster in Children, Adolescents and Young Adults (Follow-Up to Study 700401)CompletedNCT00894686Phase 4Results posted
- Immunogenicity, Safety and Interchangeability of Two Tbe Vaccines Administered According to a Conventional Schedule in ChildrenCompletedNCT00840801Phase 3Results posted
- Immunogenicity of a Commercial Batch of JEV IC51 up to 24 Months Post FillingCompletedNCT00776230Phase 3Results posted
- Study of ChimeriVax™-Japanese Encephalitis Vaccine in Toddlers in Thailand and the PhilippinesCompletedNCT00735644Phase 3Results posted
- Immunogenicity and Safety of ChimeriVax™ Japanese Encephalitis Vaccine in Thai Toddlers and ChildrenCompletedNCT00621764Phase 2Results posted
- Safety and Tolerability of the Japanese Encephalitis Vaccine IC51CompletedNCT00605085Phase 3Results posted
- Immunogenicity Study of the Japanese Encephalitis Vaccine IC51CompletedNCT00604708Phase 3Results posted